e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cystic fibrosis: clinical and laboratory studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
KL-6 serum levels in adult cystic fibrosis patients
F. Piffer, A. Airoldi, M. Di Pasquale, G. Pizzamiglio, M. Zanardelli, S. Galbiati, B. Dallari, F. Blasi (Milano, Italy)
Source:
Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Session:
Cystic fibrosis: clinical and laboratory studies
Session type:
Thematic Poster Session
Number:
4288
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Piffer, A. Airoldi, M. Di Pasquale, G. Pizzamiglio, M. Zanardelli, S. Galbiati, B. Dallari, F. Blasi (Milano, Italy). KL-6 serum levels in adult cystic fibrosis patients. Eur Respir J 2011; 38: Suppl. 55, 4288
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Serum lipid concentrations and malnutrition in adult cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 58s
Year: 2006
Serial change in serum KL-6 levels correlate with the pulmonary function variables in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018
Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Serum microRNA levels in paediatric females versus males with cystic fibrosis
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 527s
Year: 2002
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
KL-6 compared to LDH as a prognostic factor in Caucasian patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
Source: Annual Congress 2004 - Fibrosing lung diseases
Year: 2004
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001
Myeloperoxidase and lactoferrin in serum of children with exacerbation of cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 126s
Year: 2001
Serum and BALF levels of YKL-40 in patients with alveolar proteinosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005
High level of serum SP-D with normal range of KL-6 predicts a good prognosis of patients with fibrotic changes on HRCT
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept